Navigation Links
InterMune Reports Fourth Quarter And Full Year 2012 Financial Results And Business Highlights
Date:2/21/2013

BRISBANE, Calif., Feb. 21, 2013 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced results from operations for the fourth quarter and full year ended December 31, 2012.

(Logo: http://photos.prnewswire.com/prnh/20120827/SF62570LOGO)

InterMune reported Esbriet® (pirfenidone) net revenue in the fourth quarter of 2012 of $8.2 million, compared with $2.7 million in the fourth quarter of 2011.  Esbriet is InterMune's product marketed in Europe for adults with mild-to-moderate idiopathic pulmonary fibrosis (IPF), a chronic and ultimately fatal disease of the lungs.

Dan Welch, Chairman, Chief Executive Officer and President of InterMune said, "We are very pleased with our solid progress in 2012, including five consecutive quarters of Esbriet sales growth since its first European launch in September of 2011.  At year-end 2012, Esbriet was priced and launched in nine of our 15 targeted European countries including the two largest EU markets, Germany and France. 

"In 2013, we expect continued progress in completing pricing and reimbursement processes and additional Esbriet launches in Europe," Mr. Welch continued.  "We also expect to begin building our Esbriet franchise in North America after launching Esbriet in Canada in January of 2013.  Having completed in January the full enrollment of the ASCEND Phase 3 study of pirfenidone intended to support U.S. marketing approval, we are much closer to our goal of bringing Esbriet to IPF patients in the United States, who currently have no approved treatment options."Fourth Quarter and Recent Highlights

  • On October 1, 2012, Esbriet was approved in Canada for the treatment of mild to moderate IPF in adult patients and became commercially available on January 2, 2013.  IPF affects appr
    '/>"/>

  • SOURCE InterMune, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5
    2. InterMune to Present at J. P. Morgan Healthcare Conference
    3. InterMune to Release Fourth Quarter and Full Year Financial Results on February 9
    4. InterMune To Present At JMP Securities Healthcare Conference
    5. InterMune To Release Third Quarter Financial Results On November 7
    6. InterMune Reports Third Quarter 2012 Financial Results And Business Highlights
    7. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
    8. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    9. Interleukin Genetics Reports Third Quarter 2011 Financial Results
    10. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
    11. Nile Therapeutics Reports 2011 Third Quarter Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2015)... ... July 29, 2015 , ... Strong Animals™ announced today that ... dairy operation and presented at the ADSA-ASAS Joint Annual Meeting held July 12-16 in ... dairy cows and increased milk fat content. Also, feed containing Stay Strong™ for Dairy ...
    (Date:7/28/2015)... July 28, 2015 People with a common ... achieved significant and sometimes profound improvements in their hearing ... according to a new multicenter study led by specialists ... study, described online ahead of print in the journal The ... private clinics in the United States ...
    (Date:7/28/2015)... 21, 2015 Research ... addition of the "Analysis of the Global ... offering. Globally, flow cytometry remains a ... proliferation, cancer, and stem cells. But the market ... because of demand from underdeveloped nations to quantitate ...
    (Date:7/28/2015)... 28, 2015 Deerfield Management Company, L.P. today ... L.P., which will invest in groundbreaking advancements in science ... cancer, and orphan diseases. The venture capital fund will ... are developed and improve the way healthcare is delivered ... largest healthcare-focused venture funds in the sector, will donate ...
    Breaking Biology Technology:Strong Animals™ Announces South Dakota State University Research Demonstrates Stay Strong™ for Dairy Cows Improves Performance and Feed Stability 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3
    ... Myriant Technologies, Inc. (Myriant), a privately-held, biotech ... announced today the closing of a $60 ... Group (PTT Chemical), Thailand,s largest petrochemical producer. ... Myriant will utilize the investment for the ...
    ... Genomic Health, Inc. (Nasdaq: GHDX) today announced presentation ... Oncology® (ASCO®) (1) Gastrointestinal (GI) Cancer Symposium, including one ... of higher recurrence risk in stage II colon cancer, ... DX® Recurrence Score® (RS) test as well as ...
    ... of carbon one atom thick, graphene is like a ... 100 times the mobility they have in silicon. But ... the National Institute of Standards and Technology (NIST), because ... transforms its bustling speedway into steep hills and valleys ...
    Cached Biology Technology:Myriant Technologies, Inc. Announces US$60 Million Strategic Equity Investment From PTT Chemical Group 2Myriant Technologies, Inc. Announces US$60 Million Strategic Equity Investment From PTT Chemical Group 3Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 2Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 3Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 4Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 5Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 6Real-world graphene devices may have a bumpy ride 2
    (Date:7/9/2015)... Calif. , July 9, 2015  Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... Thursday, July 30, 2015 after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
    (Date:7/8/2015)... NEW YORK , July 8, 2015 ... cancer globally, and the fourth most fatal, with a ... year. The poor prognosis of pancreatic cancer patients has ... to treatment, which is not being met by the ... contains an array of products with varying molecule types ...
    (Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
    Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
    ... Coral reefs are among the ecosystems most severely threatened by ... coral species may be able to adapt to warmer oceans. ... One , an international team of researchers reports that coral ... in South-East Asian waters had previously experienced severe bleaching during ...
    ... that eating blueberries, blackberries, strawberries and other berry fruits ... prevent age-related memory loss and other changes, scientists report. ... fruits appears in ACS, Journal of Agricultural and ... Ph.D., and Marshall G. Miller point out that longer ...
    ... marine scientists made a startling discovery in the deep sea. ... surges from the seafloor and life thrives without sunlight. ... where methane rises from seeps on the ocean bottom. ... side-by-side? No one thought so. Until now. That,s ...
    Cached Biology News:Global warming threat to coral reefs: Can some species adapt? 2Hot meets cold at new deep-sea ecosystem: 'Hydrothermal seep' 2
    ... Bioluminescence assay for monitoring acetylcholinesterase (AChE) activity. ... (less than 5 min), non-radioactive and easy ... uses the natural substrate, acetylcholine. A series ... of active AChE into a change in ...
    ... Kit, Linear Template is designed for use with ... No. 3 186 148, 3 186 156). The ... constructs by PCR containing and optimized control region ... RNA polymerase and prokaryotic cell lysate. Flexible positioning ...
    ... Roto-Shake Genie is an all-in-one rotator/rocker ... performs five different mixing motions: ... as well as a combination of ... moving portion of the Vibraotme Roto-Shake ...
    ... PRMT5 Arginine methylation is an irreversible ... been linked to protein activity. At least ... identified in mammalian cells. These enzymes have ... by methylation of key proteins in several ...
    Biology Products: